Physician profile
Sumit Trivedi
NPI 1568858355
$614.94
in general payments reported to CMS, 2019-2025
11 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $56.29 · 2024: $280 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $141.14 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.68 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $94.25 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $62.11 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $35.34 | 2024-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $32.62 | 2024 | Verquvo |
| Cardiva Medical, INC. | $31.17 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $27.47 | 2024 | Linq II |
| Kestra Medical Technology Services, INC. | $23.66 | 2024 | Assure Wcd |
| Cvrx, INC. | $22.69 | 2024 | Barostim Neo System |
| Abbott Laboratories | $18.81 | 2025 | Mitraclip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Trivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.